stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / WST / Free Cash Flow

West Pharmaceutical Services, Inc. Free Cash Flow 2008–2025

West Pharmaceutical Services, Inc. (WST) annual free cash flow by fiscal year, computed from SEC filings.

Fiscal yearFree Cash FlowChange (YoY)
FY 2025$468.90M+69.6%
FY 2024$276.40M-33.3%
FY 2023$414.50M-5.7%
FY 2022$439.40M+32.9%
FY 2021$330.60M+10.9%
FY 2020$298.10M+23.8%
FY 2019$240.80M+30.9%
FY 2018$183.90M+38.8%
FY 2017$132.50M+169.3%
FY 2016$49.20M-39.1%
FY 2015$80.80M+13.8%
FY 2014$71.00M+3.5%
FY 2013$68.60M+22.3%
FY 2012$56.10M+58.9%
FY 2011$35.30M-47.5%
FY 2010$67.20M+104.9%
FY 2009$32.80M+1011.1%
FY 2008$-3.60M

Source: West Pharmaceutical Services, Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.

See the full picture for West Pharmaceutical Services, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

West Pharmaceutical Services, Inc. — frequently asked questions

What is West Pharmaceutical Services, Inc.'s free cash flow?

West Pharmaceutical Services, Inc. (WST) reported free cash flow of $468.90M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from West Pharmaceutical Services, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.

More WST financial history

Full WST fundamentals page → · All 1,500+ companies →